Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ilaria, Loperto"'
Autor:
Maria Guarino, Valentina Cossiga, Ilaria Loperto, Ilaria Esposito, Rosanna Ortolani, Andrea Fiorentino, Giuseppina Pontillo, Lucia De Coppi, Valentina Cozza, Alfonso Galeota Lanza, Giovanni Giuseppe Di Costanzo, Francesco Paolo Picciotto, Filomena Morisco
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID-19 on LT recipients compared to general population in the Campan
Externí odkaz:
https://doaj.org/article/59b0f4453d6e4f609f77e1b3855d5a22
Autor:
Paolo Montuori, Ilaria Loperto, Carmine Paolo, Davide Castrianni, Raffaele Nubi, Elvira De Rosa, Raffaele Palladino, Maria Triassi
Publikováno v:
BMC Sports Science, Medicine and Rehabilitation, Vol 13, Iss 1, Pp 1-11 (2021)
Abstract Background Among athletes, bodybuilders are more predisposed to the use of dietary supplements (DS) and hormones (H) to increase in adaptations to physical training and performance. The purpose of the study was to identify social, psychologi
Externí odkaz:
https://doaj.org/article/e1abd6d5ce4c41179e003b26c8fe58d3
Autor:
Marcello Moccia, Ilaria Loperto, Roberta Lanzillo, Antonio Capacchione, Antonio Carotenuto, Maria Triassi, Vincenzo Brescia Morra, Raffaele Palladino
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background To differentiate five formulations of Interferon Beta for the treatment of multiple sclerosis (MS) in clinical practice, by analysing persistence, adherence, healthcare resource utilisation and costs at population level. Methods I
Externí odkaz:
https://doaj.org/article/295690c5a64e4d1db974898ead7573f4
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 5, Pp 1035-1047 (2019)
Seasonal influenza is a very common disease. Yearly vaccination of at-risk population groups is a well-recognized cost-effective/cost-saving preventive measure. It is, however, unclear which available alternative has the most favorable economic profi
Externí odkaz:
https://doaj.org/article/676decc85f1f400387d6806587bf87f2
Autor:
Ausilia Elce, Aurora Daniele, Ilaria Loperto, Lucia De Coppi, Armando Sangiorgio, Angelina Vivona, Clorinda Sorrentino, Simona Iannaccone, Lucia Martiniello, Ersilia Nigro
Publikováno v:
Sports, Vol 10, Iss 3, p 44 (2022)
Mental alterations were described during the COVID-19 pandemic and sleep deprivation has been reported as a consequence of social isolation. In Italy, the COVID-19 pandemic spread out at the beginning of 2020 determining severe lockdown periods. The
Externí odkaz:
https://doaj.org/article/dc5f6b65a0ae444e811a8c91c08fc355
Autor:
Rossella Alfano, Ilaria Loperto, Arianna Scala, Teresa Angela Trunfio, Andrea Lombardi, Anna Borrelli, Maria Triassi, Giovanni Improta
Publikováno v:
2022 6th International Conference on Medical and Health Informatics.
Background. The Covid-19 pandemic has deeply impacted the oncology community. The European Society for Medical Oncology (ESMO) suggests strengthening telemedicine services, reducing clinic visits and switching to subcutaneous or oral, rather than int
Autor:
Arianna Scala, Teresa Angela Trunfio, Ilaria Loperto, Rossella Alfano, Andrea Lombardi, Anna Borrelli, Maria Triassi, Giovanni Improta
Publikováno v:
2022 6th International Conference on Medical and Health Informatics.
Autor:
Valentina Cossiga, Mario Capasso, Maria Guarino, Ilaria Loperto, Stefano Brusa, Francesco Maria Cutolo, Maria Rosaria Attanasio, Raffaele Lieto, Giuseppe Portella, Filomena Morisco
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 6; Pages: 2281
The low response to vaccines is a well-known problem in cirrhosis. We evaluated the safety and immunogenicity of booster doses in patients with chronic liver disease (CLD), comparing the humoral response in cirrhotic vs. non-cirrhotic patients, and t
Autor:
Marcello Moccia, Ilaria Loperto, Laura Santoni, Silvia Masera, Giuseppina Affinito, Antonio Carotenuto, Roberta Lanzillo, Maria Triassi, Vincenzo Brescia Morra, Raffaele Palladino
Publikováno v:
Neurodegenerative disease management. 12(3)
Aims: Natalizumab is approved as an infusion every 4 weeks (standard-interval dosing [SID]) in relapsing-remitting multiple sclerosis (MS). Extended-interval dosing (EID) reduces risk of progressive multifocal leukoencephalopathy (PML) compared with
Autor:
Ilaria Loperto, Antonio Carotenuto, Marcello Moccia, Antonio Capacchione, Vincenzo Brescia Morra, Raffaele Palladino, Maria Triassi, Roberta Lanzillo
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Health Services Research
BMC Health Services Research
Background To differentiate five formulations of Interferon Beta for the treatment of multiple sclerosis (MS) in clinical practice, by analysing persistence, adherence, healthcare resource utilisation and costs at population level. Methods In this po